Physician profile
Ira L Fedder
NPI 1962425223
$1,054,382.59
in general payments reported to CMS, 2019-2025
16 companies · $64K in 2025
The $64K reported for 2025 was more than what 89% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264K · 2020: $46K · 2021: $190K · 2022: $280K · 2023: $159K · 2024: $51K · 2025: $64K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $164K · Consulting Fee: $106K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,250 · Travel and Lodging: $1,987 · Food and Beverage: $362 · Gift: $35.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $163,801.66 |
| Consulting Fee | $106,367.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,250.00 |
| Travel and Lodging | $1,986.56 |
| Food and Beverage | $362.07 |
| Gift | $35.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $400,592.49 | 2019-2025 | Independence Mis, Independence, Viacell / Trifecta |
| Tyber Medical, LLC | $388,230.00 | 2019-2023 | |
| Medtronic USA, INC. | $142,970.64 | 2019 | |
| Medtronic, INC. | $116,704.33 | 2021-2024 | Inceptiv |
| Kuros Biosciences USA, INC | $4,301.73 | 2021-2022 | |
| Aroa Biosurgery Incorporated | $489.99 | 2022-2023 | |
| Abbott Laboratories | $388.14 | 2019-2020 | |
| Baxter Healthcare | $162.82 | 2020-2022 | |
| Integrity Implants INC. | $155.29 | 2021 | |
| Spinal Simplicity, LLC | $135.87 | 2022 | |
| Amgen INC. | $103.13 | 2020-2021 | |
| Bard Peripheral Vascular, INC. | $72.56 | 2025 | Rotarexs 6 F X 135 Cm |
| Theradaptive, INC. | $35.25 | 2025 | Osteoadapt |
| Stryker Corporation | $26.33 | 2020 | |
| Smith+Nephew, INC. | $14.02 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$40,839,217.37 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ira Fedder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.